Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B - Concepedia

Concepedia

Publication | Closed Access

Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B

549

Citations

11

References

2006

Year

Lewis R. Silverman, David R. McKenzie, Bercedis L. Peterson, James F. Holland, Jay T. Backstrom, C. L. Beach, Richard A. Larson

Journal of Clinical Oncology

Abstract

Azacitidine provides important clinical benefits for patients with high-risk MDS.

References

	Year	Citations

Page 1